Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Historical Holders from Q4 2021 to Q3 2025

Symbol
CNTX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
92.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
69M
Holdings value
$66.8M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
37
Number of buys
12
Number of sells
-14
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MPM BioImpact LLC 16.4% $8.97M 14.7M MPM BioImpact LLC 31 Dec 2024
Avidity Partners Management LP 9.9% 0% $8.91M $72.1K 9.2M +0.82% Avidity Partners Management LP 30 Sep 2025
Deep Track Capital, LP 8.27% $4.53M 7.42M Deep Track Capital, LP 31 Mar 2025
Blue Owl Capital Holdings LP 8.48% $3.88M 6.36M Blue Owl Capital Holdings LP 31 Dec 2024
GREAT POINT PARTNERS LLC 5.22% 0% $4.54M 4.68M 0% Great Point Partners, LLC 30 Sep 2025
FRANKLIN RESOURCES INC 4.5% -16% $2.44M 4M 0% Franklin Resources, Inc. 31 Mar 2025
Lehr Martin A. 2.1% $973K 1.6M Martin Lehr 31 Dec 2024

Institutional Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 69M $66.8M +$690K $0.97 37
2025 Q2 68.6M $45M -$1.72M $0.66 39
2025 Q1 71.4M $43.7M -$1.1M $0.61 42
2024 Q4 72.8M $76.4M +$15.8M $1.05 52
2024 Q3 56.7M $111M -$854K $1.96 42
2024 Q2 57M $114M +$107M $2.01 34
2024 Q1 3.94M $5.43M +$524K $1.38 25
2023 Q4 3.56M $4.02M +$1.1M $1.13 23
2023 Q3 2.58M $3.89M +$507K $1.51 22
2023 Q2 2.24M $3.58M +$1.63M $1.60 21
2023 Q1 1.28M $718K -$1.59M $0.56 19
2022 Q4 3.88M $2.54M -$384K $0.65 22
2022 Q3 4.13M $4.59M +$469K $1.11 21
2022 Q2 2.45M $5.13M -$1.02M $2.12 16
2022 Q1 2.9M $6.3M -$2.23M $2.17 12
2021 Q4 3.55M $9.44M +$8.49M $2.66 15